Development of liver-specific ribavirin-loaded nanoparticles with reduced cytotoxicity

References

• Allen, L. B., Boswell, K. H., Khwaja, T. A., Meyer, Jr, R. B., Sidwell, R. W., Witkowski, J. T., … Robins, R. K. (1978). Synthesis and antiviral acticity of some phosphates of the broad-spectrum antiviral nucleoside, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin). Journal of Medicinal Chemistry, 21, 742–746.10.1021/jm00206a005
   PubMed Web of Science ®Google Scholar
• Brochot, E., Castelain, S., Duverlie, G., Capron, D., Nguyen-Khac, E., & François, C. (2010). Ribavirin monitoring in chronic hepatitis C therapy: Anaemia versus efficacy. Antiviral Therapy, 15, 687–695.10.3851/IMP1609
   PubMed Web of Science ®Google Scholar
• Burstow, N. J., Mohamed, Z., Gomaa I, A. I., Sonderup, M. W., Cook, N. A., Waked, I., … Taylor-Robinson, S. D. (2017). Hepatitis C treatment: Where are we now? International Journal of General Medicine, 10, 39–52.10.2147/IJGM
   PubMed Web of Science ®Google Scholar
• Craparo, E. F., Teresi, G., Licciardi, M., Bondí, M. L., & Cavallaro, G. (2013). Novel composed galactosylated nanodevices containing a ribavirin prodrug as hepatic cell-targeted carriers for HCV treatment. Journal of Biomedical Nanotechnology, 9, 1107–1122.10.1166/jbn.2013.1608
   PubMed Web of Science ®Google Scholar
• Dong, Z., Li, Q., Guo, D., Shu, Y., Polli, J. E. (2015). Synthesis and evaluation of bile acid-ribavirin conjugates as prodrugs to target the liver. Journal of Pharmaceutical Sciences, 104, 2864–2876.10.1002/jps.24375
   PubMed Web of Science ®Google Scholar
• Elgart, A., Farber, S., Domb, A. J., Polacheck, I., & Hoffman, A. (2010). Polysaccharide pharmacokinetics: Amphotericin B arabinogalactan conjugate—A drug delivery system or a new pharmaceutical entity? Biomacromolecules, 11, 1972–1977.10.1021/bm100298r
   PubMed Web of Science ®Google Scholar
• Fischer, D., Li, Y., Ahlemeyer, B., Krieglstein, J., & Kissel, T. (2003). In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials, 24, 1121–1131.10.1016/S0142-9612(02)00445-3
   PubMed Web of Science ®Google Scholar
• Guo, H., Sun, S., Yang, Z., Tang, X., & Wang, Y. (2015). Strategies for ribavirin prodrugs and delivery systems for reducing the side-effect hemolysis and enhancing their therapeutic effect. Journal of Controlled Release, 209, 27–36.10.1016/j.jconrel.2015.04.016
   PubMed Web of Science ®Google Scholar
• Hecker, S. J., & Erion, M. D. (2008). Prodrugs of phosphates and phosphonates. Journal of Medicinal Chemistry, 51, 2328–2345.10.1021/jm701260b
   PubMed Web of Science ®Google Scholar
• Ishihara, T., Kaneko, K., Ishihara, T., & Mizushima, T. (2014). Development of biodegradable nanoparticles for liver-specific ribavirin delivery. Journal of Pharmaceutical Sciences, 103, 4005–4011.10.1002/jps.24219
   PubMed Web of Science ®Google Scholar
• Ishihara, T., & Mizushima, T. (2010). Techniques for efficient entrapment of pharmaceuticals in biodegradable solid micro/nanoparticles. Expert Opinion on Drug Delivery, 7, 565–575.10.1517/17425241003713486
   PubMed Web of Science ®Google Scholar
• Ishihara, T., Takahashi, M., Higaki, M., Takenaga, M., Mizushima, T., & Mizushima, Y. (2008). Prolonging the in vivo residence time of prostaglandin E1 with biodegradable nanoparticles. Pharmaceutical Research, 25, 1686–1695.10.1007/s11095-008-9549-8
   PubMed Web of Science ®Google Scholar
• Kamar, N., Izopet, J., Tripon, S., Bismuth, M., Hillaire, S., Dumortier, J., … Mallet, V. (2014). Ribavirin for chronic hepatitis E virus infection in transplant recipients. New England Journal of Medicine, 370, 1111–1120.10.1056/NEJMoa1215246
   PubMed Web of Science ®Google Scholar
• Kaneo, Y., Ueno, T., Tanaka, T., Iwase, H., Yamaguchi, Y., & Uemura, T. (2000). Pharmacokinetics and biodisposition of fluorescein-labeled arabinogalactan in rats. International Journal of Pharmaceutics, 201, 59–69.10.1016/S0378-5173(00)00405-1
   PubMed Web of Science ®Google Scholar
• Kryger, M. B., Smith, A. A., Wohl, B. M., & Zelikin, A. N. (2014). Macromolecular prodrugs for controlled delivery of ribavirin. Macromolecular Bioscience, 14, 173–185.10.1002/mabi.201300244
   PubMed Web of Science ®Google Scholar
• Levy, G. A., Adamson, G., Phillips, M. J., Scrocchi, L. A., Fung, L., Biessels, P., … Bell, D. (2006). Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activity. Hepatology, 43, 581–591.10.1002/(ISSN)1527-3350
   PubMed Web of Science ®Google Scholar
• Monnery, B. D., Wright, M., Cavill, R., Hoogenboom, R., Shaunak, S., Steinke, J. H., & Thanou, M. (2017). Cytotoxicity of polycations: Relationship of molecular weight and the hydrolytic theory of the mechanism of toxicity. International Journal of Pharmaceutics, 521, 249–258.10.1016/j.ijpharm.2017.02.048
   PubMed Web of Science ®Google Scholar
• Mori, K., Hiraoka, O., Ikeda, M., Ariumi, Y., Hiramoto, A., Wataya, Y., & Kato, N. (2013). Adenosine kinase is a key determinant for the anti-HCV activity of ribavirin. Hepatology, 58, 1236–1244.10.1002/hep.v58.4
   PubMed Web of Science ®Google Scholar
• Nakamoto, S., Kanda, T., Shirasawa, H., & Yokosuka, O. (2015). Antiviral therapies for chronic hepatitis C virus infection with cirrhosis. World Journal of Hepatology, 7, 1133–1141.10.4254/wjh.v7.i8.1133
   PubMed Web of Science ®Google Scholar
• Nimura, N., & Kinoshita, T. (1980). Fluorescent labeling of fatty acids with 9-anthryldiazomethane (ADAM) for high performance liquid chromatography. Analytical Letters, 13, 191–202.10.1080/00032718008082552
   Web of Science ®Google Scholar
• Parhamifar, L., Andersen, H., Wu, L., Hall, A., Hudzech, D., & Moghimi, S. M. (2014). Polycation-mediated integrated cell death processes. Advances in Genetics, 88, 353–398.
   PubMed Web of Science ®Google Scholar
• Park, J. U., Ishihara, T., Kano, A., Akaike, T., & Maruyama, A. (1999). Preparation of dendritic graft copolymer consisting of poly-(L-lysine) and arabinogalactan as a hepatocyte specific DNA carrier. Preparative Biochemistry and Biotechnology, 29, 353–370.10.1080/10826069908544934
   PubMed Web of Science ®Google Scholar
• Pathak, A., Vyas, S. P., & Gupta, K. C. (2008). Nano-vectors for efficient liver specific gene transfer. International Journal of Nanomedicine, 3, 31–49.
   PubMed Web of Science ®Google Scholar
• Poelstra, K., Prakash, J., & Beljaars, L. (2012). Drug targeting to the diseased liver. Journal of Controlled Release, 161, 188–197.10.1016/j.jconrel.2012.02.011
   PubMed Web of Science ®Google Scholar
• Russmann, S., Grattagliano, I., Portincasa, P., Palmieri, V. O., & Palasciano, G. (2006). Ribavirin-induced anemia: Mechanisms, risk factors and related targets for future research. Current Medicinal Chemistry, 13, 3351–3357.10.2174/092986706778773059
   PubMed Web of Science ®Google Scholar
• Satake, K., Okuyama, T., Ohashi, M., & Shinoda, T. (1960). The spectrophotometric determination of amine, amino acid and peptide with 2, 4, 6-trinitrobenzene 1-sulfonic acid. The Journal of Biochemistry, 47, 654–660.10.1093/oxfordjournals.jbchem.a127107
   Web of Science ®Google Scholar
• Shah, S. M., Pathak, P. O., Jain, A. S., Barhate, C. R., & Nagarsenker, M. S. (2013). Synthesis, characterization, and in vitro evaluation of palmitoylated arabinogalactan with potential for liver targeting. Carbohydrate Research, 367, 41–47.10.1016/j.carres.2012.11.025
   PubMed Web of Science ®Google Scholar
• Stefano, G., Colonna, F. P., Bongini, A., Busi, C., Mattioli, A., & Fiume, L. (1997). Ribavirin conjugated with lactosaminated poly-L-lysine: Selective delivery to the liver and increased antiviral activity in mice with viral hepatitis. Biochemical Pharmacology, 54, 357–363.10.1016/S0006-2952(97)00223-2
   PubMed Web of Science ®Google Scholar
• Yasuno, S., Murata, T., Kokubo, K., Yamaguchi, T., & Kamei, M. (1997). Two-mode analysis by high-performance liquid chromatography of ρ-aminobenzoic ethyl ester-derivatized monosaccharides. Bioscience, Biotechnology, and Biochemistry, 61, 1944–1946.10.1271/bbb.61.1944
   PubMed Web of Science ®Google Scholar